SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-056971
Filing Date
2024-05-09
Accepted
2024-05-09 16:12:29
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tyra-20240331.htm   iXBRL 10-Q 1295629
2 EX-10.3 tyra-ex10_3.htm EX-10.3 39467
3 EX-31.1 tyra-ex31_1.htm EX-31.1 15887
4 EX-31.2 tyra-ex31_2.htm EX-31.2 16066
5 EX-32.1 tyra-ex32_1.htm EX-32.1 8738
6 EX-32.2 tyra-ex32_2.htm EX-32.2 8701
  Complete submission text file 0000950170-24-056971.txt   6490212

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tyra-20240331.xsd EX-101.SCH 1012310
65 EXTRACTED XBRL INSTANCE DOCUMENT tyra-20240331_htm.xml XML 1192700
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

IRS No.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40800 | Film No.: 24930745
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)